However, a much larger longitudinal study involving 858 individuals from the Veterans Affairs Diabetes Trial (VADT) cohort has shown that PAI-1 plasma levels predict the development of retinopathy in T2D with a 12% increased risk for every 10 ng/dl increase in PAI-1 levels [62]. Here, SERPINE1 is linked to retinal disorder.